Vycor Medical, Inc.
VYCO
$0.175
$0.000.00%
OTC PK
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 13.75% | -4.13% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 13.75% | -4.13% | |||
| Cost of Revenue | 4.24% | 34.60% | |||
| Gross Profit | 15.84% | -9.79% | |||
| SG&A Expenses | -1.63% | -1.63% | |||
| Depreciation & Amortization | 0.00% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.89% | 3.05% | |||
| Operating Income | 499.22% | -166.32% | |||
| Income Before Tax | 166.75% | -474.63% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 166.75% | -474.63% | |||
| Earnings from Discontinued Operations | -- | 100.00% | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 161.92% | -476.12% | |||
| EBIT | 499.22% | -166.32% | |||
| EBITDA | 1,906.06% | -90.88% | |||
| EPS Basic | 111.67% | -2,900.00% | |||
| Normalized Basic EPS | 171.43% | -600.00% | |||
| EPS Diluted | 110.00% | -2,900.00% | |||
| Normalized Diluted EPS | 157.14% | -600.00% | |||
| Average Basic Shares Outstanding | 0.00% | -0.01% | |||
| Average Diluted Shares Outstanding | 15.87% | -0.01% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||